Sprache: Englisch
Verlag: Cambridge University Press, 2014
ISBN 10: 1107435943 ISBN 13: 9781107435940
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 72,88
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Sprache: Englisch
Verlag: Cambridge University Press, 2014
ISBN 10: 1107435943 ISBN 13: 9781107435940
Anbieter: Kennys Bookstore, Olney, MD, USA
EUR 105,62
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. This book focuses on the new discipline of translational medicine as it pertains to drug development within the pharmaceutical and biotechnology industry. Editor(s): Littman, Bruce H.; Krishna, Rajesh. Num Pages: 384 pages, 49 b/w illus. 16 tables. BIC Classification: MMG. Category: (P) Professional & Vocational; (U) Tertiary Education (US: College). Dimension: 256 x 178 x 20. Weight in Grams: 718. . 2014. Paperback. . . . . Books ship from the US and Ireland.
Sprache: Englisch
Verlag: Cambridge University Press, 2011
ISBN 10: 0521886457 ISBN 13: 9780521886451
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 110,11
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Sprache: Englisch
Verlag: Cambridge University Press, 2014
ISBN 10: 1107435943 ISBN 13: 9781107435940
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book, edited by two innovative leaders in the field, focuses on the new discipline of translational medicine as it pertains to drug development within the pharmaceutical and biotechnology industry. Translational medicine seeks to translate biological and molecular knowledge of disease and how drugs work into innovative development strategies that reduce the cost and increase the speed of delivering new medicines for patients. This book outlines general strategies, biomarker development, imaging tools, translational human models and examples of their application to real drug development. The latest thinking is presented by researchers from many of the world's leading drug development companies, including Pfizer, Merck, Eli Lilly, Abbott and Novartis, as well as academic institutions and public-private partnerships that support translational research. This book is essential for anyone interested in translational medicine from a variety of backgrounds: university institutes, medical schools, pharmaceutical companies and drug development researchers and decision-makers.
Sprache: Englisch
Verlag: Cambridge University Press, 2011
ISBN 10: 0521886457 ISBN 13: 9780521886451
Anbieter: Kennys Bookstore, Olney, MD, USA
EUR 160,46
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. This book focuses on the new discipline of translational medicine as it pertains to drug development within the pharmaceutical and biotechnology industry. Editor(s): Krishna, Rajesh; Littman, Bruce H. Num Pages: 384 pages, 49 b/w illus. 16 tables. BIC Classification: MBGR1; TCB. Category: (U) Tertiary Education (US: College). Dimension: 262 x 188 x 26. Weight in Grams: 938. . 2011. Illustrated. hardcover. . . . . Books ship from the US and Ireland.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 160,92
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 1st edition. 344 pages. 10.00x7.00x1.00 inches. In Stock.
Sprache: Englisch
Verlag: Cambridge University Press, 2011
ISBN 10: 0521886457 ISBN 13: 9780521886451
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book, edited by two innovative leaders in the field, focuses on the new discipline of translational medicine as it pertains to drug development within the pharmaceutical and biotechnology industry. Translational medicine seeks to translate biological and molecular knowledge of disease and how drugs work into innovative development strategies that reduce the cost and increase the speed of delivering new medicines for patients. This book outlines general strategies, biomarker development, imaging tools, translational human models and examples of their application to real drug development. The latest thinking is presented by researchers from many of the world's leading drug development companies, including Pfizer, Merck, Eli Lilly, Abbott and Novartis, as well as academic institutions and public-private partnerships that support translational research. This book is essential for anyone interested in translational medicine from a variety of backgrounds: university institutes, medical schools, pharmaceutical companies and drug development researchers and decision-makers.